Abstract
An observational descriptive study was carried out of the healthcare resources consumed during 1 year by a sample of patients with type II diabetes of a healthcare area in southern Spain. A total of 517 patients with a mean duration of disease of 9.7±8 years were assessed. A total annual health cost of €4,278/patient was calculated (direct €2,504; indirect €1,774). Multiple regression analysis showed an independent association between total costs and obesity, male sex, number of hospitalizations related to diabetes, permanent disability, macrovascular complications, and both micro- and macrovascular complications. Our findings confirm both the high economic cost associated with type II diabetes and the direct relationship between the costs of the disease and the presence of obesity, male sex, hospitalizations related to diabetes, permanent disability and chronic complications.
Similar content being viewed by others
References
King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414–1431
Carral F, Olveira G, Ramos I et al. (2000) Calidad de vida en pacientes con diabetes mellitus tipo 2 ingresados en un hospital de tercer nivel. Endocrinol Nutr 47: 24–28
Eiser C, Tooke JE (1993) Quality-of-life evaluation in diabetes. Pharmacoeconomics 4: 85–91
Rubin RJ, Altman WM, Mendelson DN (1994) Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78: 809A-809F
American Diabetes Association (2003) Economic costs of diabetes in the United States in 2002. Diabetes Care 26: 917–932
American Diabetes Association (1998) Economic consequences of diabetes mellitus in the United States in 1997. Diabetes Care 21: 296–309
Kangas T, Aro S, Koivisto VA et al. (1996) Structure and costs of health care of diabetic patients in Finland. Diabetes Care 19: 494–497
Gisbert R, Brosa M (1998) Costes sanitarios y evaluación económica. SOIKOS: Barcelona
Mata M, Antoñanzas F, Tafalla M, Sanz P (2002) El coste de la diabetes tipo 2 en España. El estudio CODE-2. Gac Sanit 16: 511–520
Krosnick A (1988) Economic impact of type II diabetes mellitus. Prim Care 15: 423–432
Henriksson F, Jönsson B (1998) Diabetes: the cost of illness in Sweden. J Intern Med 244: 461–468
Norlund A, Apelqvist J, Bitzén O et al. (2001) Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 250: 57–65
Persson U (1995) The indirect costs of morbidity in type II diabetic patients. Pharmacoeconomics 8 [Suppl 1]: 28–32
Peisker P (1999) Vademecum Internacional 40 Edición. Medicom: Madrid
Anonymous (2000) Consejería de Salud del Gobierno Canario. Memoria estadística
García F, Molins G, Farre J et al. (1995) La contabilidad de coste en atención primaria: cartera de servicios. Aten Primaria 16: 141–145
Carral F, Olveira G, Salas J et al. (2002) Estimate of care resource utilization incurred by diabetic patients in a Spanish hospital. Diab Res Clin Pract 56: 27–34
Ministerio de Trabajo y Asuntos Sociales (2000) Encuesta de salarios ESA-14. Ministerio de Trabajo y Asuntos Sociales: Madrid
Anonymous (nd) Pensiones contributivas del Sistema de Seguridad Social. Ministerio de trabajo y asuntos sociales: Madrid
Brandle M, Zhou H, Smith BRK et al. (2003) The direct medical cost of type 2 diabetes. Diabetes Care 26: 2300–2304
Redekop WK, Koopmanschap MA, Rutten GE et al. (2002) Resource consumption and costs in Dutch patients with type 2 diabetes mellitus: results from 29 general practices. Diabet Med 19: 246–253
Jonsson B, CODE-2 Advisory Board (2002) Revealing the cost of type II diabetes in Europe. Diabetologia 45: S5–12
Olveira G, Olvera P, Carral F et al. (2004) Excess cost due to hospitalization of persons with diabetes in Andalucía (Spain). Diabetes Care 27: 1904–1909
Gilmer TP, O’Connor PJ, Manning WG, Rush WA (1997) The cost to health plans of poor glycemic control. Diabetes Care 20: 1847–1853
Wagner EH, Sandhu N, Newton KM et al. (2001) Effect of improved glycemic control on health care costs and utilization. JAMA 285: 182–189
Gray A, Raikou M, McGuire A et al. (2000) Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 320: 1373–1378
Acknowledgements
This study was financed in part by two research grants from the Fondo de Investigaciones Sanitarias (FIS 03/0572) and the Consejería de Salud of the Junta de Andalucía (Regional Government of Andalusia; project 200/03). We are grateful to Dr. Encarnación Benítez of the Preventive Medicine and Public Health Service of Puerta del Mar Hospital of Cadiz for her collaboration in the statistical analysis for this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ballesta, M., Carral, F., Olveira, G. et al. Economic cost associated with type II diabetes in Spanish patients. Eur J Health Econ 7, 270–275 (2006). https://doi.org/10.1007/s10198-006-0367-9
Issue Date:
DOI: https://doi.org/10.1007/s10198-006-0367-9